Overview of key legislative changes in the pharmaceutical and healthcare sectors — Q1 2025

REVERA Belarus presents a fresh analytical report covering recent regulatory changes affecting the pharmaceutical and healthcare industries in Belarus and the EAEU region. The document offers a detailed analysis of updated rules for drug and medical device registration, revised requirements for patient information leaflets, changes in laboratory diagnostics, advertising restrictions, and much more.

Authors: Iryna Navitskaya, Denis Valukevich, Sergey Sushchenya

---

Dear journalists, the use of materials from the REVERA website in publications is only permitted with our written consent.

To obtain approval, please contact us via email at: i.antonova@revera.legal or Telegram: https://t.me/PR_revera